Salient Pharmaceuticals

About:

Salient is developing CASAD™, a proprietary composition proven to adsorb a range of toxins and inflammatory proteins.

Website: http://www.salientpharmaceuticals.com

Top Investors: Texas Venture Labs, Texas Wide Open for Business

Description:

Salient is a Texas-based company formed in 2007 to explore the pharmaceutical application of its proprietary composition of a rare, all-natural mineral. This composition has been proven to adsorb a range of toxins and inflammatory proteins commonly associated with diarrhea. Salient’s compound, CASAD™, is envisioned to be a “platform” product effective across a spectrum of conditions from Cancer Therapy-Induced Diarrhea to infectious disease and chronic GI conditions. It also has the potential to be used as a rescue agent for other drugs with toxic side effects.